SG Americas Securities
IRON icon

SG Americas Securities’s Disc Medicine IRON Stock Holding History

SG Americas Securities’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Sell
7,704
-3,522
-31% -$242K ﹤0.01% 2248
2026
Q1 		$718K Sell
11,226
-9,896
-47% -$687K ﹤0.01% 1969
2025
Q4 		$1.68M Buy
21,122
+13,058
+162% +$1.1M ﹤0.01% 1639
2025
Q3 		$533K Buy
+8,064
New +$480K ﹤0.01% 2056
2025
Q2 		– Sell
-14,329
Closed -$711K – 3259
2025
Q1 		$711K Buy
14,329
+6,253
+77% +$348K ﹤0.01% 1482
2024
Q4 		$512K Buy
8,076
+3,212
+66% +$186K ﹤0.01% 1327
2024
Q3 		$239K Buy
4,864
+793
+19% +$37.2K ﹤0.01% 2347
2024
Q2 		$183K Buy
4,071
+1,247
+44% +$42.4K ﹤0.01% 2213
2024
Q1 		$176K Sell
2,824
-6,311
-69% -$409K ﹤0.01% 2076
2023
Q4 		$528K Buy
+9,135
New +$468K ﹤0.01% 1442
2021
Q4 		– Sell
-408
Closed -$49K – 3591
2021
Q3 		$49K Buy
+408
New +$55.8K ﹤0.01% 3738

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities's IRON Position: Q2 2026 in Review

SG Americas Securities reduced its Disc Medicine (IRON) stake by 31% in Q2 2026, selling an estimated $242K and leaving 7,704 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

SG Americas Securities first reported a position in IRON in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.68M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • SG Americas Securities held 7,704 shares of Disc Medicine worth $563K as of Q2 2026.
  • SG Americas Securities sold 3,522 Disc Medicine shares in Q2 2026, an estimated $242K.
  • Disc Medicine made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2248 holding.
  • SG Americas Securities first reported a position in Disc Medicine in Q3 2021 and has held it in 11 quarters since.
  • SG Americas Securities's Disc Medicine position peaked at $1.68M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.